These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 12374682)
1. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients. Castagnetta LA; Granata OM; Traina A; Ravazzolo B; Amoroso M; Miele M; Bellavia V; Agostara B; Carruba G Clin Cancer Res; 2002 Oct; 8(10):3146-55. PubMed ID: 12374682 [TBL] [Abstract][Full Text] [Related]
2. In vitro model of mammary estrogen metabolism: structural and kinetic differences between catechol estrogens 2- and 4-hydroxyestradiol. Dawling S; Hachey DL; Roodi N; Parl FF Chem Res Toxicol; 2004 Sep; 17(9):1258-64. PubMed ID: 15377160 [TBL] [Abstract][Full Text] [Related]
3. Spectral characterization of catechol estrogen quinone (CEQ)-derived DNA adducts and their identification in human breast tissue extract. Markushin Y; Zhong W; Cavalieri EL; Rogan EG; Small GJ; Yeung ES; Jankowiak R Chem Res Toxicol; 2003 Sep; 16(9):1107-17. PubMed ID: 12971798 [TBL] [Abstract][Full Text] [Related]
4. Variants in estrogen metabolism and biosynthesis genes and urinary estrogen metabolites in women with a family history of breast cancer. Greenlee H; Chen Y; Kabat GC; Wang Q; Kibriya MG; Gurvich I; Sepkovic DW; Bradlow HL; Senie RT; Santella RM; Ahsan H Breast Cancer Res Treat; 2007 Mar; 102(1):111-7. PubMed ID: 16850246 [TBL] [Abstract][Full Text] [Related]
5. Urinary hydroxyestrogens and breast cancer risk among postmenopausal women: a prospective study. Wellejus A; Olsen A; Tjonneland A; Thomsen BL; Overvad K; Loft S Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2137-42. PubMed ID: 16172222 [TBL] [Abstract][Full Text] [Related]
6. In vitro generation of peroxynitrite by 2- and 4-hydroxyestrogens in the presence of nitric oxide. Paquette B; Cantin AM; Kocsis-Bédard S; Barry S; Lemay R; Jay-Gerin JP Chem Res Toxicol; 2001 May; 14(5):547-54. PubMed ID: 11368553 [TBL] [Abstract][Full Text] [Related]
8. Moderate coffee and alcohol consumption improves the estrogen metabolite profile in adjuvant treated breast cancer patients: a pilot study comparing pre- and post-operative levels. Klug TL; Bågeman E; Ingvar C; Rose C; Jernström H Mol Genet Metab; 2006 Dec; 89(4):381-9. PubMed ID: 16978896 [TBL] [Abstract][Full Text] [Related]
9. Urinary estrogen metabolites and breast cancer: a case-control study. Kabat GC; Chang CJ; Sparano JA; Sepkovie DW; Hu XP; Khalil A; Rosenblatt R; Bradlow HL Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):505-9. PubMed ID: 9232337 [TBL] [Abstract][Full Text] [Related]
10. Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. van Duursen MB; Sanderson JT; de Jong PC; Kraaij M; van den Berg M Toxicol Sci; 2004 Oct; 81(2):316-24. PubMed ID: 15254334 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 4-(hydroxyalkyl)estradiols and related compounds. Lovely CJ; Bhat AS; Coughenour HD; Gilbert NE; Brueggemeier RW J Med Chem; 1997 Nov; 40(23):3756-64. PubMed ID: 9371241 [TBL] [Abstract][Full Text] [Related]
12. Analysis of multiplex endogenous estrogen metabolites in human urine using ultra-fast liquid chromatography-tandem mass spectrometry: a case study for breast cancer. Huang J; Sun J; Chen Y; Song Y; Dong L; Zhan Q; Zhang R; Abliz Z Anal Chim Acta; 2012 Jan; 711():60-8. PubMed ID: 22152797 [TBL] [Abstract][Full Text] [Related]
13. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657 [TBL] [Abstract][Full Text] [Related]
14. Catechol estrogen conjugates and DNA adducts in the kidney of male Syrian golden hamsters treated with 4-hydroxyestradiol: potential biomarkers for estrogen-initiated cancer. Devanesan P; Todorovic R; Zhao J; Gross ML; Rogan EG; Cavalieri EL Carcinogenesis; 2001 Mar; 22(3):489-97. PubMed ID: 11238191 [TBL] [Abstract][Full Text] [Related]
15. Urinary estrogen metabolites and breast cancer: differential pattern of risk found with pre- versus post-treatment collection. Fowke JH; Qi D; Bradlow HL; Shu XO; Gao YT; Cheng JR; Jin F; Zheng W Steroids; 2003 Jan; 68(1):65-72. PubMed ID: 12475724 [TBL] [Abstract][Full Text] [Related]
16. [Biological effect of estrogen metabolites in human breast cancer]. Imoto S Nihon Geka Gakkai Zasshi; 1992 May; 93(5):505-17. PubMed ID: 1614394 [TBL] [Abstract][Full Text] [Related]
17. The 2-/16α-Hydroxylated Estrogen Ratio-Breast Cancer Risk Hypothesis: Insufficient Evidence for its Support. Stanczyk FZ J Steroid Biochem Mol Biol; 2020 Jul; 201():105685. PubMed ID: 32320758 [TBL] [Abstract][Full Text] [Related]
18. Estrogens, enzyme variants, and breast cancer: a risk model. Crooke PS; Ritchie MD; Hachey DL; Dawling S; Roodi N; Parl FF Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1620-9. PubMed ID: 16985022 [TBL] [Abstract][Full Text] [Related]
19. The ability of four catechol estrogens of 17beta-estradiol and estrone to induce DNA adducts in Syrian hamster embryo fibroblasts. Yagi E; Barrett JC; Tsutsui T Carcinogenesis; 2001 Sep; 22(9):1505-10. PubMed ID: 11532873 [TBL] [Abstract][Full Text] [Related]
20. Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. van Landeghem AA; Poortman J; Nabuurs M; Thijssen JH Cancer Res; 1985 Jun; 45(6):2900-6. PubMed ID: 3986816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]